Diagnos Laboratorium Utama Tbk. vs Merdeka Gold Resources Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Merdeka Gold Resources Tbk. trades at Rp5,725 (market cap 84.34T, 14.53M 24h volume). The key difference: Merdeka Gold Resources Tbk. is far larger — about 271.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Merdeka Gold Resources Tbk. is more actively traded (14.53M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | EMAS | |
|---|---|---|
Market Cap | 310.75B | 84.34T |
Volume | 963.6K | 14.53M |
Lot | 9.64K | 145.32K |
Turnover | 217.67M | 84.06B |
Average Price | 225.89 | 5,784.58 |
Value | 217.67M | 84.06B |
Indicative Equilibrium Price | 226 | 5,725 |
Indicative Equilibrium Volume | 1K | 3.32K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Merdeka Gold Resources Tbk (formerly PT Pani Bersama Jaya) (the Company), was established in Republic of Indonesia based on Deed of Establishment No. 87 dated 20 November 2015 made before Humberg Lie, S.H., S.E., M.Kn., Notary in North Jakarta. The ultimate parent entity of the Company is PT Merdeka Copper Gold Tbk (MCG). Meanwhile, MCG is jointly controlled by PT Provident Capital Indonesia and PT Saratoga Investama Sedaya Tbk, which are respectively controlled by Winato Kartono and Edwin Soeryadjaya.
Read more on EMAS →